Professor Martin Ng is an interventional cardiologist with strong interests in clinical, scientific and technological innovation in cardiology. As founder of the transcatheter heart valve program at RPA, he has established a program that has set benchmarks for excellence in clinical outcomes and that has pioneered world firsts in minimally invasive treatment of heart disease. Synergistic to his clinical interests, Prof. Ng heads a National Health and Medical Research Council (NHMRC) supported bench-to-bedside biomedical research program, that seeks to address unmet patient needs by developing new treatments for heart disease.

He is head of Translational Research and Bioengineering at the Heart Research Institute and has won numerous awards for research and innovation. His invention of an expandable seal to stop leaks around percutaneous heart valves was awarded First Place in the Stanford Biodesign Innovation (Stanford University, California, U.S.) and has been met with international acclaim.

In 2010, Prof. Ng was awarded the prestigious Royal Prince Alfred Hospital Foundation Medal (2010) for world-first research into developing new stents and materials for the treatment of heart disease; the Royal Australasian College of Physicians' Young Investigator of the Year in 2001; the CJ Martin Fellowship from the National Health and Medical Research Council in 2004-2005; and the Advanced E-Team Award from the National Collegiate Inventors and Innovators Alliance (NCIIA) in 2006-2007.

Prof. Ng graduated with First Class Honours in Medicine from the University of Sydney, where he completed his MBBS in 1993. He holds a PhD in cardiovascular medicine from the University of Sydney. He undertook his training in interventional cardiology at Stanford University Medical Center (Stanford, California, U.S.A.)